Fibrofind

FibroFind is a contract research company that has established 3D human tissue models of fibrosis and inflammation in multiple organ systems that maintain the architectural integrity, functionality and metabolic activities of the tissue over an extended period (6 days+). All major epithelial, endothelial and resident immune cell types are maintained and the tissue responds dynamically to physiologically relevant inducers of fibrosis/inflammation. This platform is able to validate drug targets and determine the anti-fibrotic and/or anti-inflammatory activities of candidate drugs through a variety of readouts that include soluble matrix factors, gene expression and histology. FibroFind offer this platform as a drug testing service to pharma and biotech companies.